Applied dna completes buildout of gmp facility for lineadna ivt templates

- signals start of new commercialization phase for linearx subsidiary - - company negotiating gmp supply agreement - - company reaffirms strategic restructuring timeline - stony brook, ny / accesswire / january 10, 2025 / applied dna sciences, inc. (nasdaq:apdn) ("applied dna" or the "company"), a leader in pcr-based dna technologies, today announced the completion of the buildout of its new good manufacturing practices (gmp) manufacturing facility (the "facility") within its stony brook, new york, headquarters and readiness to accept orders for the manufacture of lineadna™ ivt templates that clients can utilize for the production of mrna clinical trial materials. the facility is undergoing final testing and is expected to be fully operational by the end of the current month.
APDN Ratings Summary
APDN Quant Ranking